The event of cell tradition programs for the naturalistic propagation, self-renewal and differentiation of cells ex vivo is a excessive purpose of molecular engineering. Regardless of vital success in recent times, the excessive value of up-scaling cultures, the necessity for xeno-free tradition situations, and the diploma of mimicry of the natural extracellular matrix attainable in vitro utilizing designer substrates proceed to pose obstacles to the interpretation of cell-based technologies.
On this regard, the ZT biopolymer is a protein-based, steady, scalable, and economical cell substrate of excessive promise. ZT relies on the naturally occurring meeting of two human proteins: titin-Z1Z2 and telethonin. These protein constructing blocks are strong scaffolds that may be conveniently functionalized with full-length proteins and bioactive peptidic motifs by genetic manipulation, previous to self-assembly.
The polymer is, thereby, totally encodable. Functionalized variations of the ZT polymer have been proven to efficiently maintain the long-term culturing of human embryonic stem cells (hESCs), human induced pluripotent stem cells (hiPSCs), and murine mesenchymal stromal cells (mMSCs).
Pluripotency of hESCs and hiPSCs was retained for the longest interval assayed (four months). Outcomes level to the big potential of the ZT system for the creation of a modular, pluri-functional biomaterial for cell-based purposes.
Maxwell®: An Unsupervised Studying Method for 5P Medication.
Within the 5P medication (Customized, Preventive, Participative, Predictive and Pluri-expert), the final pattern is to course of information by displacing the barycenter of the data from hospital centered programs to the affected person centered ones by his private medical information.
 EGF |
|
90201-3 |
BPS Bioscience |
1000 µg |
EUR 335 |
|
Description: Human Epidermal Growth Factor (GenBank Accession No. NM_001963), a.a. 971- 1023, MW=6.2 kDa, expressed in an E. coli expression system. |
EGF |
|
LF-PR003 |
Abfrontier |
200 ug |
EUR 170.4 |
|
Description: EGF protein |
EGF |
|
E13-007-1 |
EnoGene |
10μg |
EUR 99.6 |
EGF |
|
E8ET1704-33 |
EnoGene |
100ul |
EUR 275 |
|
Description: Available in various conjugation types. |
EGF |
|
cyt-217 |
ProSpec Tany |
100µg |
EUR 60 |
|
Description: Recombinant Human Epidermal Growth Factor |
EGF |
|
ant-169 |
ProSpec Tany |
0.5mg |
EUR 275 |
|
Description: Mouse Anti Human Epidermal Growth Factor |
 EGF Long |
|
cyt-798 |
ProSpec Tany |
20µg |
EUR 60 |
|
Description: Recombinant Human Epidermal Growth Factor Long |
 Mouse EGF |
|
90200-1 |
BPS Bioscience |
100 µg |
EUR 85 |
|
Description: Mouse Epidermal Growth Factor (GenBank Accession No. NM_010113), a.a. 977- 1029, MW=6.0 kDa, expressed in an E. coli expression system. |
Mouse EGF |
|
90200-2 |
BPS Bioscience |
500 µg_x000D_ |
EUR 210 |
|
Description: Mouse Epidermal Growth Factor (GenBank Accession No. NM_010113), a.a. 977- 1029, MW=6.0 kDa, expressed in an E. coli expression system. |
Mouse EGF |
|
90200-3 |
BPS Bioscience |
1000 µg |
EUR 320 |
|
Description: Mouse Epidermal Growth Factor (GenBank Accession No. NM_010113), a.a. 977- 1029, MW=6.0 kDa, expressed in an E. coli expression system. |
 EGF Mouse |
|
P2558-.1 |
ApexBio |
100 µg |
EUR 129.6 |
EGF Mouse |
|
P2558-.5 |
ApexBio |
500 µg |
EUR 240 |
EGF Mouse |
|
P2558-1 |
ApexBio |
1 mg |
EUR 373.2 |
 EGF， Human |
|
E34M120-100HP |
EnoGene |
100 μg |
EUR 155 |
 EGF，Swine |
|
E34M018S |
EnoGene |
5 μg |
EUR 295 |
 EGF，Mouse |
|
E34M065M |
EnoGene |
100 μg |
EUR 155 |
 EGF Pichia |
|
PR27007 |
Neuromics |
500 ug |
EUR 381.6 |
 EGF, Pichia |
|
cyt-332 |
ProSpec Tany |
100µg |
EUR 60 |
|
Description: Recombinant Human Epidermal Growth Factor, Pichia |
 EGF Protein |
|
abx169012-1mg |
Abbexa |
1 mg |
EUR 543.6 |
|
|
 EGF protein |
|
30R-1056 |
Fitzgerald |
100 ug |
EUR 321.6 |
|
Description: Purified recombinant Human EGF protein |
EGF protein |
|
30R-2331 |
Fitzgerald |
500 ug |
EUR 380.4 |
|
Description: Purified recombinant Human EGF protein |
EGF protein |
|
30R-2332 |
Fitzgerald |
500 ug |
EUR 390 |
|
Description: Purified recombinant Mouse EGF protein |
EGF protein |
|
30R-2333 |
Fitzgerald |
20 ug |
EUR 252 |
|
Description: Purified recombinant Rat EGF protein |
EGF protein |
|
30R-AE003 |
Fitzgerald |
1 mg |
EUR 457.2 |
|
Description: Purified recombinant Human EGF protein |
EGF protein |
|
30R-AE004 |
Fitzgerald |
100 ug |
EUR 159.6 |
|
Description: Purified recombinant Human EGF protein |
EGF protein |
|
30R-AE025 |
Fitzgerald |
100 ug |
EUR 327.6 |
|
Description: Purified recombinant Human EGF protein |
EGF Protein |
|
abx069820-1mg |
Abbexa |
1 mg |
EUR 1296 |
|
|
 EGF antibody |
|
10-E39A |
Fitzgerald |
500 ug |
EUR 679.2 |
|
Description: Mouse monoclonal EGF antibody |
EGF antibody |
|
10R-2038 |
Fitzgerald |
100 ul |
EUR 483.6 |
|
Description: Mouse monoclonal EGF antibody |
EGF antibody |
|
10R-2176 |
Fitzgerald |
100 ul |
EUR 483.6 |
|
Description: Mouse monoclonal EGF antibody |
EGF antibody |
|
10R-2969 |
Fitzgerald |
100 ug |
EUR 318 |
|
Description: Mouse monoclonal EGF antibody |
EGF antibody |
|
10R-2985 |
Fitzgerald |
100 ug |
EUR 318 |
|
Description: Mouse monoclonal EGF antibody |
EGF antibody |
|
10R-7766 |
Fitzgerald |
500 ug |
EUR 678 |
|
Description: Mouse monoclonal EGF antibody |
EGF antibody |
|
20C-CR1085GP |
Fitzgerald |
100 ug |
EUR 177.6 |
|
Description: Goat polyclonal EGF antibody |
EGF antibody |
|
20R-1772 |
Fitzgerald |
100 ug |
EUR 807.6 |
|
Description: Rabbit polyclonal EGF antibody |
EGF antibody |
|
38447-100ul |
SAB |
100ul |
EUR 302.4 |
EGF antibody |
|
70R-EG001 |
Fitzgerald |
50 ug |
EUR 327.6 |
|
Description: Affinity purified Goat polyclonal EGF antibody |
EGF antibody |
|
70R-ER012 |
Fitzgerald |
50 ug |
EUR 327.6 |
|
Description: Affinity purified Rabbit polyclonal EGF antibody |
EGF antibody |
|
70-ER40 |
Fitzgerald |
50 ug |
EUR 340.8 |
|
Description: Affinity purified Rabbit polyclonal EGF antibody |
 EGF Antibody |
|
49545-100ul |
SAB |
100ul |
EUR 399.6 |
EGF Antibody |
|
49545-50ul |
SAB |
50ul |
EUR 286.8 |
EGF antibody |
|
70R-12248 |
Fitzgerald |
100 ug |
EUR 483.6 |
|
Description: Rabbit polyclonal EGF antibody |
EGF antibody |
|
70R-12249 |
Fitzgerald |
100 ug |
EUR 483.6 |
|
Description: Rabbit polyclonal EGF antibody |
EGF antibody |
|
70R-13940 |
Fitzgerald |
100 ug |
EUR 386.4 |
|
Description: Affinity purified Goat polyclonal EGF antibody |
EGF antibody |
|
70R-15294 |
Fitzgerald |
100 ug |
EUR 392.4 |
|
Description: Rabbit polyclonal EGF antibody |
EGF antibody |
|
70R-5697 |
Fitzgerald |
50 ug |
EUR 560.4 |
|
Description: Rabbit polyclonal EGF antibody |
EGF Antibody |
|
35720-100ul |
SAB |
100ul |
EUR 302.4 |
EGF Antibody |
|
5022-100 |
Biovision |
each |
EUR 379.2 |
EGF Antibody |
|
5022-30T |
Biovision |
each |
EUR 175.2 |
EGF Antibody |
|
5023R-100 |
Biovision |
each |
EUR 379.2 |
EGF Antibody |
|
5023R-30T |
Biovision |
each |
EUR 175.2 |
EGF Antibody |
|
1-CSB-PA06244A0Rb |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against EGF. Recognizes EGF from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
 egf Antibody |
|
1-CSB-PA24449A0Rb |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against egf. Recognizes egf from Zebrafish. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:500-1:5000 |
EGF Antibody |
|
1-CSB-PA846755 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against EGF. Recognizes EGF from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:1000-1:5000, WB:1:500-1:2000, IHC:1:25-1:100 |
EGF Antibody |
|
1-CSB-PA942209 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against EGF. Recognizes EGF from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:50-1:200 |
EGF Antibody |
|
1-CSB-PA007939 |
Cusabio |
|
|
|
|
|
Description: A polyclonal antibody against EGF. Recognizes EGF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000 |
EGF Antibody |
|
F47084-0.08ML |
NSJ Bioreagents |
0.08 ml |
EUR 140.25 |
|
Description: This gene encodes a member of the epidermal growth factor superfamily. The encoded protein is synthesized as a large precursor molecule that is proteolytically cleaved to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. This protein acts by binding the high affinity cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternate splicing results in multiple transcript variants. |
EGF Antibody |
|
F47084-0.4ML |
NSJ Bioreagents |
0.4 ml |
EUR 322.15 |
|
Description: This gene encodes a member of the epidermal growth factor superfamily. The encoded protein is synthesized as a large precursor molecule that is proteolytically cleaved to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. This protein acts by binding the high affinity cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternate splicing results in multiple transcript variants. |
EGF Antibody |
|
R36053-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
|
Description: Additional name(s) for this target protein: Epidermal growth factor |
EGF Antibody |
|
R30469 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: Epidermal growth factor(EGF) is a growth factor that plays an important role in the regulation of cell growth, proliferation and differentiation by binding to its receptor EGFR. EGF locus is mapped to 4q21-4qter. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bones. EGF results in cellular proliferation, differentiation, and survival while plays an important physiological role in the maintenance of oro-esophageal and gastric tissue integrity. |
EGF Antibody |
|
R31863 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: EGF is known as epidermal growth factor. This gene encodes a member of the epidermal growth factor superfamily. The encoded preproprotein is proteolytically processed to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. Additionally, it acts by binding with high affinity to the cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. |
EGF Antibody |
|
R31864 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
|
Description: EGF is known as epidermal growth factor. This gene encodes a member of the epidermal growth factor superfamily. The encoded preproprotein is proteolytically processed to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. Additionally, it acts by binding with high affinity to the cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. |
EGF Antibody |
|
E92720 |
EnoGene |
100ul |
EUR 255 |
|
Description: Available in various conjugation types. |
EGF Antibody |
|
E38PA5289 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
EGF Antibody |
|
E10-20414 |
EnoGene |
100μg/100μl |
EUR 225 |
|
Description: Available in various conjugation types. |
EGF Antibody |
|
E10-30015 |
EnoGene |
100μg/100μl |
EUR 225 |
|
Description: Available in various conjugation types. |
EGF Antibody |
|
E035720 |
EnoGene |
100μg/100μl |
EUR 255 |
|
Description: Available in various conjugation types. |
EGF Antibody |
|
E19-7063 |
EnoGene |
100μg/100μl |
EUR 225 |
|
Description: Available in various conjugation types. |
EGF Antibody |
|
E18-5148-1 |
EnoGene |
50μg/50μl |
EUR 145 |
|
Description: Available in various conjugation types. |
EGF Antibody |
|
E18-5148-2 |
EnoGene |
100μg/100μl |
EUR 225 |
|
Description: Available in various conjugation types. |
EGF Antibody |
|
E300887 |
EnoGene |
200ul |
EUR 275 |
|
Description: Available in various conjugation types. |
) EGF (1-51) |
|
cyt-1115 |
ProSpec Tany |
100µg |
EUR 80 |
|
Description: Recombinant Human Epidermal Growth Factor (1-51 a.a.) |
 EGF GMP, CF |
|
PR15112CF |
Neuromics |
200 ug |
EUR 481.2 |
) EGF, (Leu 21) |
|
cyt-466 |
ProSpec Tany |
20µg |
EUR 60 |
|
Description: Recombinant Human Epidermal Growth Factor 21-Leu |
) EGF (His tag) |
|
EGPS009-10 |
EnoGene |
10μg |
EUR 30 |
EGF (His tag) |
|
EGPS009-50 |
EnoGene |
50μg |
EUR 70 |
) rec EGF (human) |
|
H-7490.0100 |
Bachem |
0.1mg |
EUR 194.4 |
|
Description: Sum Formula: C270H395N73O83S7; CAS# [62253-63-8] |
rec EGF (human) |
|
H-7490.0500 |
Bachem |
0.5mg |
EUR 457.2 |
|
Description: Sum Formula: C270H395N73O83S7; CAS# [62253-63-8] |
 EGF Mouse mAb |
|
E2220372 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
EGF Mouse mAb |
|
E2220389 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
 EGF Rabbit pAb |
|
A12916-100ul |
Abclonal |
100 ul |
EUR 369.6 |
EGF Rabbit pAb |
|
A12916-200ul |
Abclonal |
200 ul |
EUR 550.8 |
EGF Rabbit pAb |
|
A12916-20ul |
Abclonal |
20 ul |
EUR 219.6 |
EGF Rabbit pAb |
|
A12916-50ul |
Abclonal |
50 ul |
EUR 267.6 |
EGF Rabbit pAb |
|
A13615-100ul |
Abclonal |
100 ul |
EUR 369.6 |
EGF Rabbit pAb |
|
A13615-200ul |
Abclonal |
200 ul |
EUR 550.8 |
EGF Rabbit pAb |
|
A13615-20ul |
Abclonal |
20 ul |
EUR 219.6 |
EGF Rabbit pAb |
|
A13615-50ul |
Abclonal |
50 ul |
EUR 267.6 |
EGF Rabbit pAb |
|
A2720-100ul |
Abclonal |
100 ul |
EUR 369.6 |
EGF Rabbit pAb |
|
A2720-200ul |
Abclonal |
200 ul |
EUR 550.8 |
EGF Rabbit pAb |
|
A2720-20ul |
Abclonal |
20 ul |
EUR 219.6 |
EGF Rabbit pAb |
|
A2720-50ul |
Abclonal |
50 ul |
EUR 267.6 |
EGF Rabbit pAb |
|
E2502720 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
EGF Rabbit pAb |
|
E2513615 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
EGF Rabbit pAb |
|
E2381803 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
EGF Rabbit pAb |
|
E2251575 |
EnoGene |
100ul |
EUR 225 |
|
Description: Available in various conjugation types. |
) EGF Protein (OVA) |
|
20-abx165531 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2064.00
-
EUR 828.00
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Rat EGF protein |
|
PRP1211-100ug |
Abbkine |
100 μg |
EUR 149 |
|
Description: Rat EGF protein, expressed in E. coli |
Rat EGF protein |
|
PRP1211-1mg |
Abbkine |
1 mg |
EUR 889 |
|
Description: Rat EGF protein, expressed in E. coli |
Rat EGF protein |
|
PRP1211-20ug |
Abbkine |
20 μg |
EUR 59 |
|
Description: Rat EGF protein, expressed in E. coli |
Rat EGF protein |
|
PRP1211-500ug |
Abbkine |
500 μg |
EUR 589 |
|
Description: Rat EGF protein, expressed in E. coli |
In the present day, using synthetic intelligence for supporting this transition exhibits actual limitations in its implementation in operational follow, each on the stage of affected person care, but in addition within the basic each day lifetime of the well being skilled, due to the medico-legal imperatives induced by the guarantees of the ‘5P medication’.
On this paper, we suggest to fill this hole by introducing an authentic synthetic intelligence platform, named Maxwell, which follows an unsupervised studying method consistent with the medico-legal imperatives of the ‘5P medication’. We describe the useful platform traits and illustrate them by two examples of clustering in genomics and magnetic resonance imaging.
